Pediatrix Medical Group, Inc. (MD)
NYSE: MD · Real-Time Price · USD
31.45
+0.16 (0.51%)
Nov 9, 2026, 11:25 AM EST - Market open
Pediatrix Medical Group Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,959 | 1,914 | 2,013 | 1,995 | 1,972 | 1,911 | |
Revenue Growth | 1.91% | -4.92% | 0.92% | 1.15% | 3.18% | 10.22% |
Cost of Revenue | 1,447 | 1,420 | 1,559 | 1,573 | 1,505 | 1,398 |
Gross Profit | 511.69 | 493.7 | 454.34 | 421.57 | 467.03 | 513.24 |
Selling, General & Admin | 249.94 | 240.79 | 238.44 | 227.54 | 231.4 | 263.36 |
Operating Expenses | 273.71 | 262.62 | 270.66 | 263.71 | 267.03 | 295.5 |
Operating Income | 237.98 | 231.09 | 183.68 | 157.85 | 200 | 217.74 |
Interest Expense | -33.3 | -35.97 | -40.74 | -42.08 | -39.7 | -68.72 |
Interest & Investment Income | 19.87 | 19.05 | 5.77 | 4.34 | 3.67 | 13.65 |
Earnings From Equity Investments | 4.28 | 3.63 | 2.34 | 2.06 | 1.72 | 1.91 |
EBT Excluding Unusual Items | 228.83 | 217.8 | 151.05 | 122.17 | 165.7 | 164.58 |
Merger & Restructuring Charges | -25.39 | -22.27 | -64.26 | -2.22 | -27.31 | -22.1 |
Impairment of Goodwill | - | - | -150.64 | -148.31 | - | - |
Gain (Loss) on Sale of Investments | - | - | - | -20 | - | - |
Gain (Loss) on Sale of Assets | - | 20.91 | -9.7 | - | - | 7.28 |
Asset Writedown | - | - | -27.79 | - | - | - |
Other Unusual Items | - | - | - | - | -57.02 | -14.53 |
Pretax Income | 203.43 | 216.43 | -101.34 | -48.36 | 81.37 | 135.23 |
Income Tax Expense | 53.34 | 51.04 | -2.27 | 12.05 | 18.81 | 27.24 |
Earnings From Continuing Operations | 150.09 | 165.39 | -99.07 | -60.41 | 62.56 | 107.99 |
Earnings From Discontinued Operations | - | - | - | - | 3.77 | 22.95 |
Net Income to Company | 150.09 | 165.39 | -99.07 | -60.41 | 66.33 | 130.94 |
Minority Interest in Earnings | - | - | - | - | 0 | 0.03 |
Net Income | 150.09 | 165.39 | -99.07 | -60.41 | 66.34 | 130.96 |
Net Income to Common | 150.09 | 165.39 | -99.07 | -60.41 | 66.34 | 130.96 |
Net Income Growth | -7.46% | - | - | - | -49.35% | - |
Shares Outstanding (Basic) | 80 | 84 | 83 | 82 | 83 | 85 |
Shares Outstanding (Diluted) | 82 | 85 | 83 | 82 | 84 | 86 |
Shares Change | -3.57% | 2.33% | 1.37% | -2.28% | -1.99% | 2.92% |
EPS (Basic) | 1.88 | 1.97 | -1.19 | -0.73 | 0.79 | 1.54 |
EPS (Diluted) | 1.83 | 1.94 | -1.19 | -0.73 | 0.78 | 1.53 |
EPS Growth | -4.32% | - | - | - | -48.62% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 209.59 | 252.63 | 184.55 | 104 | 137.23 | 44.49 |
Free Cash Flow Per Share | 2.56 | 2.96 | 2.21 | 1.26 | 1.63 | 0.52 |
Gross Margin | 26.12% | 25.80% | 22.57% | 21.14% | 23.68% | 26.86% |
Operating Margin | 12.15% | 12.07% | 9.13% | 7.91% | 10.14% | 11.39% |
Profit Margin | 7.66% | 8.64% | -4.92% | -3.03% | 3.36% | 6.85% |
Free Cash Flow Margin | 10.70% | 13.20% | 9.17% | 5.21% | 6.96% | 2.33% |
EBITDA | 261.75 | 252.91 | 215.91 | 194.02 | 235.64 | 249.89 |
EBITDA Margin | 13.36% | 13.21% | 10.73% | 9.73% | 11.95% | 13.08% |
D&A For EBITDA | 23.78 | 21.83 | 32.23 | 36.17 | 35.64 | 32.15 |
EBIT | 237.98 | 231.09 | 183.68 | 157.85 | 200 | 217.74 |
EBIT Margin | 12.15% | 12.07% | 9.13% | 7.91% | 10.14% | 11.39% |
Effective Tax Rate | 26.22% | 23.58% | - | - | 23.11% | 20.14% |